Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STANDARD BIOTOOLS INC. Director's Dealing 2011

Nov 16, 2011

32853_dirs_2011-11-16_59f6786d-5629-4012-a385-62d404401d02.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2011-11-14

Reporting Person: Smith William Maxwell (VP, Legal Affairs & GC)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-11-14 Common Stock M 1511 $1.82 Acquired 51056 Direct
2011-11-14 Common Stock S 1511 $13.8353 Disposed 49545 Direct
2011-11-14 Common Stock M 1489 $1.82 Acquired 51034 Direct
2011-11-14 Common Stock S 1489 $13.8353 Disposed 49545 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-11-14 Employee Stock Option (Right to Buy) $1.82 M 1511 Disposed 2011-12-04 Common Stock (1511) Direct
2011-11-14 Employee Stock Option (Right to Buy) $1.82 M 1489 Disposed 2013-07-15 Common Stock (1489) Direct

Footnotes

F1: The sales reported by Mr. Smith were effected pursuant to a Rule 10b5-1 trading plan adopted on September 6, 2011.

F2: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $13.45 to $13.89, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.

F3: The Option fully vested on December 4, 2005.

F4: The Option fully vested on April 1, 2007.